These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36564445)

  • 81. Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls.
    Desmet AS; Cirillo C; Tack J; Vandenberghe W; Vanden Berghe P
    Elife; 2017 Aug; 6():. PubMed ID: 28825895
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Gastrointestinal Dysfunction and Neuropathologic Correlations in Parkinson Disease.
    Mrabet S; Ben Ali N; Achouri A; Dabbeche R; Najjar T; Haouet S; Belal S
    J Clin Gastroenterol; 2016 Oct; 50(9):e85-90. PubMed ID: 27433810
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Enteric Pathologic Manifestations of Alpha-Synucleinopathies.
    Punsoni M; Friedman JH; Resnick M; Donahue JE; Yang DF; Stopa EG
    Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):543-548. PubMed ID: 29189256
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity.
    Stoll AC; Sortwell CE
    Neurobiol Dis; 2022 Sep; 171():105804. PubMed ID: 35764290
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Myo1d promotes alpha-synuclein transfer from brain microvascular endothelial cells to pericytes through tunneling nanotubes.
    Duan Q; Zhang Q; Nie K; Huang R; Yang J; He P; Tie Z; Huang H; Ma G; Zhang Y; Gao Y; Wang L
    iScience; 2023 Aug; 26(8):107458. PubMed ID: 37575183
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Human tripartite cortical network model for temporal assessment of alpha-synuclein aggregation and propagation in Parkinson's Disease.
    Kapucu FE; Tujula I; Kulta O; Sukki L; Ryynänen T; Gram H; Vuolanto V; Vinogradov A; Kreutzer J; Jensen PH; Kallio P; Narkilahti S
    NPJ Parkinsons Dis; 2024 Jul; 10(1):138. PubMed ID: 39069518
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.
    Ratan Y; Rajput A; Pareek A; Pareek A; Jain V; Sonia S; Farooqui Z; Kaur R; Singh G
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254673
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
    Anis E; Xie A; Brundin L; Brundin P
    Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration.
    Natale G; Ryskalin L; Busceti CL; Biagioni F; Fornai F
    Arch Ital Biol; 2017 Sep; 155(3):118-130. PubMed ID: 29220864
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Aggregation of alpha-synuclein in enteric neurons does not impact function in vitro.
    Bindas AJ; Nichols KN; Roth NJ; Brady R; Koppes AN; Koppes RA
    Sci Rep; 2022 Dec; 12(1):22211. PubMed ID: 36564445
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
    Manfredsson FP; Luk KC; Benskey MJ; Gezer A; Garcia J; Kuhn NC; Sandoval IM; Patterson JR; O'Mara A; Yonkers R; Kordower JH
    Neurobiol Dis; 2018 Apr; 112():106-118. PubMed ID: 29341898
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cross-linking for the analysis of α-synuclein in the enteric nervous system.
    Corbillé AG; Neunlist M; Derkinderen P
    J Neurochem; 2016 Dec; 139(5):839-847. PubMed ID: 27637918
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
    Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
    Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Histone Deacetylases as Epigenetic Targets for Treating Parkinson's Disease.
    Li Y; Gu Z; Lin S; Chen L; Dzreyan V; Eid M; Demyanenko S; He B
    Brain Sci; 2022 May; 12(5):. PubMed ID: 35625059
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.